NCT06530251 2026-03-04A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)AkesoPhase 1/2 Recruiting280 enrolled
NCT04843943 2021-04-14Sintilimab Combined With Bevacizumab Biosimilar for Potentially Resectable Intermediate HCCFudan UniversityPhase 1/2 Unknown30 enrolled